The ‘Wild West’ of peptides is booming. Here’s what’s real, what’s risky and what’s next

In the early 2020s, interest in GLP-1 weight loss drugs exploded. Now, as we move deeper into the decade, a new buzzword is taking over: peptides. And the demand for peptides continues to surge. “The GLP-1s put it on the map, and then people were like, ‘Well, what’s next?’” said Evan Miller, found...

Redirecting to full article...